A special key for unlocking the door to targeted therapies of breast cancer.
Document type:
Journal Article; Article
Author(s):
Lindemann, K; Harbeck, N; Lengyel, E; Resau, JH
Abstract:
Personalized medicine and targeted therapy is the best hope for patients with cancer. C-Met-HGF/SF inhibition may be an effective cancer treatment for ductal carcinoma of the breast as it is expected to be an important signalling target in a large number of malignancies.